Research progress of bevacizumab combined with chemotherapy for the treatment of cervical cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 207-210, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-473085
ABSTRACT
As one of the latest anti-angiogenic tumor molecular targeted therapy drugs,bevacizumab has achieved better clinical effect on the treatment of gastrointestinal cancer and ovarian cancer.This review focuses on the significance of bevacizumab combined with chemotherapy for the treatment of cervical cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS